Home Dialysis Does Not Have the Monopoly on Low Cost - Archive ouverte HAL
Article Dans Une Revue Kidney International Reports Année : 2023

Home Dialysis Does Not Have the Monopoly on Low Cost

Résumé

End-stage kidney disease (ESKD) is a major challenge for health care systems around the world because of its ever-rising rates and the ensuing rise in health care costs. In France, the cost of caring for patients with ESKD was estimated at €4.1 billion in 2019, which is 2.5% of the total budget of the health insurance funds that is spent on 1.4% of the general population. Health care systems must attempt to provide appropriate, high-quality, and economically sustainable care that meets the needs and desires of patients with ESKD. Patients aspire to remain independent if at all possible, continuing to have a social life and pursue their profession.1, 2, 3 The objective of this study was to compare the cost of 4 dialysis modalities that enable patients to play a substantial role in their own care and have social and professional lives. The dialysis modalities include the following: (i) nonassisted hemodialysis in self-care units (scHD), (ii) nonassisted automated peritoneal dialysis (naAPD), (iii) daily home hemodialysis (dhHD), and (iv) non–facility-based nocturnal extended hours hemodialysis (neHD) (Supplementary Population and Method). (introd.)
Fichier principal
Vignette du fichier
pdf (26.71 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03932425 , version 1 (10-01-2023)

Licence

Identifiants

Citer

E. Laruelle, F. Huré, T. Dolley-Hitze, I. Vanorio-Vega, Sahar Bayat, et al.. Home Dialysis Does Not Have the Monopoly on Low Cost. Kidney International Reports, 2023, 8 (1), pp.188-196. ⟨10.1016/j.ekir.2022.10.021⟩. ⟨hal-03932425⟩
66 Consultations
25 Téléchargements

Altmetric

Partager

More